Stockholm
According to the newspaper, it would be the vaccine Imvanex and the antiviral drug Tecovirimat. Imvanex is produced by the German company Nordic, Tecovirimat by the American Siga technologies. The EU has not yet signed a contract with both pharmaceutical manufacturers, although this could happen ‘soon’, according to Bergstrom. “We should have a contract in a week or so,” he told the newspaper. “And maybe some limited deliveries in June.”
The joint procurement was prompted by the European procurement of corona vaccines, which many Member States look back on with satisfaction. The Netherlands still has sufficient doses of Imvanex in stock and is not participating. The vaccines are intended for, for example, care providers who work with patients..
–
